EDGAR Filing Documents for 0001213900-21-032645

Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:

SEC Accession No. 0001213900-21-032645

Filing Date

2021-06-16

Accepted

2021-06-16 09:37:16

Documents

Effectiveness Date

2021-06-16

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	ea142713-s3mef_oramedpharma.htm	S-3MEF	38628
2	OPINION OF SULLIVAN & WORCESTER LLP AS TO VALIDITY OF THE SECURITIES BEING REGIS	ea142713ex5-1_oramedpharma.htm	EX-5.1	10415
3	CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	ea142713ex23-1_oramedpharma.htm	EX-23.1	3086
4	GRAPHIC	ex5-1_001.jpg	GRAPHIC	6726
5	GRAPHIC	ex5-1_002.jpg	GRAPHIC	1755
6	GRAPHIC	image_001.jpg	GRAPHIC	21417
	Complete submission text file	0001213900-21-032645.txt		94913

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164

ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)